How Can Platform Approaches to CMC Development Improve AAV Production and Scale-Up for Viral Vectors?
Recorded: February 2025
This webinar will discuss Pharmaron’s approach to developing and scaling up the Pharmaron AAV Production Platform, the benefits of applying the platform, and how this can accelerate AAV products to BLA/MAA submission.
Agenda
1. Introduction to AAV
- AAV as a therapeutic
- Importance of serotype
- Key considerations of platform (cell line, plasmids, manufacturing process)
2. Overcoming Common AAV Production Challenges
- Yield
- Production quality
3. Effective Scale-Up of AAV Manufacturing Processes
- Transitioning from bench to production scale for clinical manufacture
- Pharmaron Platform data overview
4. Platform Lifecycle Development
- Continuous improvements of the AAV Production platform driven by innovation
- Case Studies
5. Summary
- Recap of key points
